Dysplasia is a precancerous condition that can develop in Barrett's esophagus.

Dysplasia is defined as a precancerous condition in which cells that are very similar to cancer cells grow in an organ but have not yet acquired the ability to invade into tissue or metastasize (spread to areas distant from where they started).

The risk of developing esophageal cancer increases if dysplasia is detected on esophageal biopsy. Without dysplasia, the risk of progression to cancer is 0.2-0.5% per year. This risk increases to 0.7% per year with low-grade dysplasia, and approximately 7% per year with high-grade dysplasia. [1]

Patients who have Barrett's esophagus with dysplasia may need more frequent upper endoscopies or endoscopic treatment.

BE prog

Learn more about management of Barrett's with dysplasia

Degrees of Dysplasia

Reference:

1. Shaheen NJ, Falk GW, Iyer PG, Gerson LB; American College of Gastroenterology. ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus. Am J Gastroenterol. 2016 Jan;111(1):30-50.